DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

06922 CRYOFOCUS-B

Closed Add to Porfolio
Index Constituent : None
Major Shareholders Li Hui & Associates (58.93%)
Shenzhen Gao Ling Tiancheng III Investment Co., Ltd. (8.08%)
Hangzhou Proxima Innovative Investment Management L.P. (Limited Partnership) (6.53%)
Suzhou Industrial Park New Phase 2 Venture Capital Enterprise (5.14%)		 Sector Health Care & Biotechnology
Web Site http://www.cryofocus.com Tel (86 21) 2097-7850
Email IR@cryfocus.com Fax N/A
Related Equities N/A
Principal Activities The Group is a medical device company with a main focus on the field of cryoablation minimally-invasive interventional treatment. Based on the Group’s liquid nitrogen cryoablation technology, it mainly engages in research and development of cardiovascular innovation minimally invasive based on the cryomedical technology and other related medical products.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top